Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 14/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | RXRB | P28702 | 1/20 | 0.50 |
| ▸ | RXRG | P48443 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9628202 | 0.88 | MAOB (0.54) | MAOBALOX5MAOARXRARXRB | |
| SCHEMBL31703580 | 0.81 | ALOX5 (0.59) | MAOBALOX5MAOARXRARXRB | |
| SCHEMBL9627307 | 0.81 | MAOB (0.71) | MAOBALOX5MAOARXRARXRB | |
| SCHEMBL9627603 | 0.80 | MAOB (0.56) | MAOBALOX5MAOARXRARXRB | |
| SCHEMBL16552346 | 0.80 | MAOB (1.00) | MAOBALOX5MAOA | |
| SCHEMBL12050814 | 0.78 | BCHE (0.53) | MAOB | |
| SCHEMBL16552398 | 0.78 | MAOB (0.73) | MAOBALOX5MAOA | |
| SCHEMBL11659351 | 0.76 | GPR34 (0.61) | MAOBMAOARXRARXRBRXRG | |
| SCHEMBL16634946 | 0.75 | ITGB3 (0.55) | MAOBALOX5 | |
| SCHEMBL29397771 | 0.75 | ITGB3 (0.55) | MAOBALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0477184-A1 | INHIBITORS OF MONO-AMINE OXIDASE, PROCESS FOR THEIR PREPARATION, AND THEIR USE IN THERAPEUTICS. | FOURNIER INDUSTRIE ET SANTE (FR) | 1992-04-01 | — | — | EP | disclosed |
| WO-1990011997-A2 | INHIBITORS OF MONO-AMINE OXIDASE, PROCESS FOR THEIR PREPARATION, AND THEIR USE IN THERAPEUTICS. | FOURNIER INNOVATION ET SYNERGIE (FR) | 1990-10-18 | — | — | WO | disclosed |